NCT05117554View on ClinicalTrials.gov

Study to Investigate the Safety, Tolerability, and Pharmacokinetic Profile With Oral AB521 in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

November 9, 2021

Primary Completion Date

February 17, 2023

Study Completion Date

February 17, 2023

Conditions
Healthy Participants
Interventions
DRUG

casdatifan

Capsule

DRUG

Placebo

Capsule

DRUG

Midazolam

Syrup solution

Trial Locations (1)

Unknown

Investigational Site, Groningen

Sponsors
All Listed Sponsors
lead

Arcus Biosciences, Inc.

INDUSTRY